Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Shimada

Showing results (331-340 of 336) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 336 results.
American Heart Journal|June 15, 2016
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) TrialYuichi J Shimada, Sameer Bansilal, Stephen D Wiviott, et al.
JACC. Advances|February 14, 2026
Outcomes After Repeat Alcohol Septal Ablation in Patients With Obstructive Hypertrophic CardiomyopathyTakashi Hiruma, Mitsunobu Kitamura, Itaru Takamisawa, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 1, 1996
[Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 2. studies on clinical usefulness and serological diagnostic standards]T Kishimoto, Y Kubota, T Matsushima, et al.
The Japanese Journal of Antibiotics|July 9, 1999
[Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs]M Inoue, S Kubo, A Saito, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2014
Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failureKiyotake Ishikawa, Kenneth M Fish, Lisa Tilemann, et al.
Neurology|December 10, 2003
Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's diseaseHiroshi Kase, S Aoyama, M Ichimura, et al.
Pageof 34

Showing results (331-340 of 336) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 336 results.
American Heart Journal|June 15, 2016
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) TrialYuichi J Shimada, Sameer Bansilal, Stephen D Wiviott, et al.
JACC. Advances|February 14, 2026
Outcomes After Repeat Alcohol Septal Ablation in Patients With Obstructive Hypertrophic CardiomyopathyTakashi Hiruma, Mitsunobu Kitamura, Itaru Takamisawa, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 1, 1996
[Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 2. studies on clinical usefulness and serological diagnostic standards]T Kishimoto, Y Kubota, T Matsushima, et al.
The Japanese Journal of Antibiotics|July 9, 1999
[Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs]M Inoue, S Kubo, A Saito, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2014
Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failureKiyotake Ishikawa, Kenneth M Fish, Lisa Tilemann, et al.
Neurology|December 10, 2003
Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's diseaseHiroshi Kase, S Aoyama, M Ichimura, et al.
Pageof 34